The antibody , administered at repeated doses of up to 8 mg-kg , was generally well tolerated , and the pharmacokinetic characteristics of BTT-1023 in psoriasis patients were consistent with those observed in a previously completed study in rheumatoid arthritis RA patients .
### Instruction: What is the sentiment of this news? Please choose an answer from {negative/neutral/positive}
### Input: The antibody , administered at repeated doses of up to 8 mg-kg , was generally well tolerated , and the pharmacokinetic characteristics of BTT-1023 in psoriasis patients were consistent with those observed in a previously completed study in rheumatoid arthritis RA patients .
### Response: neutral